FABP1

Fatty acid-binding protein, liver · P07148 · FABP1 on Sugi Atlas →

42,258 patent compounds predicted against FABP1, 34,646 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL132895	0.51	3/20
SCHEMBL182221	0.43	2/20
Oleic Acid (SCHEMBL1138)	1.00	1/20
Oleic Acid (SCHEMBL1139)	1.00	1/20
Tacrine (SCHEMBL2828)	1.00	1/20
Erucic Acid (SCHEMBL5987)	1.00	1/20
Erucic Acid (SCHEMBL5988)	1.00	1/20
Erucic Acid (SCHEMBL6297)	1.00	1/20
Elaidic Acid (SCHEMBL6693)	1.00	1/20
Nervonic Acid (SCHEMBL21103)	1.00	1/20
Nervonic Acid (SCHEMBL21104)	1.00	1/20
Palmitoleic Acid (SCHEMBL33310)	1.00	1/20
Palmitoleic Acid (SCHEMBL33311)	1.00	1/20
Vaccenic Acid (SCHEMBL38907)	1.00	1/20
Vaccenic Acid (SCHEMBL38908)	1.00	1/20
Oleic Acid (SCHEMBL51637)	1.00	1/20
Nervonic Acid (SCHEMBL52329)	1.00	1/20
SCHEMBL52733	1.00	1/20
SCHEMBL52734	1.00	1/20
SCHEMBL53302	1.00	1/20

Clinical trials — most relevant to FABP1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Tubular Markers in Response to Saxagliptin Therapy	PHASE4	COMPLETED
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)	PHASE4	COMPLETED
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults	PHASE3	UNKNOWN
Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis	PHASE3	COMPLETED
Prediction of NEC With Urinary iFABP	PHASE2	WITHDRAWN
Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients	nan	RECRUITING
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors	nan	NOT_YET_RECRUITING
Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance	nan	COMPLETED
Plasma i-FABP as Predictor for Irreversible Bowel Ischemia	nan	UNKNOWN
The Detrimental Course of Acute Intestinal Ischemia	nan	UNKNOWN
Fatty Liver Among Employees at Banha University	nan	COMPLETED
Inflamation, Gut Leakage, Iron Status After 6000m Ergometer Test in Elite Rowers.	nan	COMPLETED
HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4	nan	RECRUITING
Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy	nan	NOT_YET_RECRUITING
Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery	nan	COMPLETED
Role of FGF21 in Breast Cancer	nan	NOT_YET_RECRUITING
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD	nan	COMPLETED
Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes	nan	COMPLETED
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease	nan	COMPLETED
Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human	nan	COMPLETED
Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients	nan	COMPLETED
Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease	nan	UNKNOWN
Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation	nan	COMPLETED
I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis	nan	RECRUITING
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)	nan	COMPLETED
Intestinal Ischemia Biomarker in Patients With Chronic Mesenteric Ischemia	nan	RECRUITING
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences	nan	NOT_YET_RECRUITING
Dietary Protein and Hepatic Fat Accumulation	nan	COMPLETED
Biomarkers in the Diagnosis and Prognosis of NAFLD	nan	RECRUITING
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)	nan	NOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a FABP1 binder may also engage these)

Protein	Name	Similarity
P49924	—	1.000	P49924 →
P12710	—	1.000	P12710 →
P80425	—	0.999	P80425 →
P02692	—	0.999	P02692 →
Q4VBT1	—	0.997	Q4VBT1 →
Q8JJ04	—	0.993	Q8JJ04 →
O42494	—	0.993	O42494 →
P81399	—	0.992	P81399 →
P83409	—	0.989	P83409 →
P81400	—	0.988	P81400 →
P80226	—	0.988	P80226 →
P0C241	—	0.987	P0C241 →
P80856	—	0.986	P80856 →
Q9I8L5	—	0.986	Q9I8L5 →
P31416	—	0.985	P31416 →
Q66RP5	—	0.984	Q66RP5 →
P81653	—	0.984	P81653 →
P51162	—	0.983	P51162 →
Q1AMT3	—	0.983	Q1AMT3 →
P41496	—	0.982	P41496 →
P80020	—	0.982	P80020 →
Q90239	—	0.981	Q90239 →
FABP6	Gastrotropin	0.981	landscape →
P31417	—	0.981	P31417 →
P41509	—	0.980	P41509 →
O45035	—	0.980	O45035 →
P50119	—	0.979	P50119 →
P02690	—	0.978	P02690 →
P10790	—	0.978	P10790 →
P29498	—	0.978	P29498 →